Hair Rescue: Parental perceptions hinder the success of HPV vaccine

Friday, December 13, 2013

Parental perceptions hinder the success of HPV vaccine

Rochester , Minnesota : A Mayo Clinic doctor and two pediatric experts say that perceptions of parents are the biggest obstacle to vaccine human papilloma virus (HPV ) , and many of these ideas are wrong . The comments are published in an editorial on why the rates of HPV vaccination remain low in Expert Review of Clinical Immunology ( Expert Review of Clinical Immunology ) .

" The worst mistake of parents is that the HPV vaccine is not necessary ," says Dr. Robert Jacobson , a pediatrician at Children's Center at Mayo Clinic and lead author of the editorial. " That idea is not only wrong , but dangerous to spread . The latest figures show that annually at least twelve thousand unvaccinated women develop cervical cancer from HPV . " Other misperceptions are that HPV vaccines are not safe and that are administered at a very tender age.
Dr. Jacobson wrote the editorial with Dr. James Roberts of the Medical University of South Carolina and Dr. Paul Darden 's Center for Health Sciences at the University of Oklahoma.

What should doctors do ?
Overcoming this kind of perception of parents require more than we currently do doctors , the authors explain . The normal intent of providing information is not enough , so physicians should engage in a conversation with the parents to know what their concerns are , share with them how you know it is now known , summarizing the scientific aspect focusing on parental concerns and vehemently express their recommendations based on the situation and their professional and scientific position. In addition, doctors must find a way to communicate outside the office with the parents of teenage girls because most of these patients rarely go to a medical appointment. The media can also play an important role in the future of vaccination programs against HPV function.
Currently available vaccines are Gardasil (Merck & Co.) and Cervarix (GlaxoSmithKline ) . These vaccines prevent cancers caused by human papillomavirus . In the U.S., every year about 21,000 people develop these cancers , including cancer of the cervix . Although since 2006 the universal recommendation is to administer the vaccine, U.S. rates for the completion of the three doses of the vaccine among girls aged 13 to 17 years hovered around 35 percent in the years 2011 and 2012 .
Moreover, an amount exceeding 50 percent of the U.S. population will be infected with HPV , a sexually transmitted disease . Most people overcome the infection within two years, but those who do not develop pre-cancerous and cancerous cells that lead to the 21 000 annual cases of cancer.
The authors note that the safety of HPV vaccines was established before his production authorization and monitoring studies conducted since then hundreds of thousands of people who have received continue to underpin this thesis . In addition, vaccines require three doses administered over a period of three months. While the Advisory Committee on Immunization Practices recommended the vaccine for girls 11 to 12 years , the same committee authorizes doctors start with vaccination from age 9. The vaccines provide lifelong immunity and younger girls respond better to vaccination than older adolescents or young adults . When the vaccine is administered in young adolescents , the series is completed well before any sexual exposure and better immune response of the organism fail .

No comments:

Post a Comment